A detailed history of Algert Global LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Algert Global LLC holds 36,391 shares of RNA stock, worth $1.12 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
36,391
Previous 38,253 4.87%
Holding current value
$1.12 Million
Previous $1.76 Million 39.78%
% of portfolio
0.02%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$29.08 - $52.5 $54,146 - $97,755
-1,862 Reduced 4.87%
36,391 $1.06 Million
Q3 2024

Nov 12, 2024

SELL
$37.21 - $48.14 $160,375 - $207,483
-4,310 Reduced 10.13%
38,253 $1.76 Million
Q2 2024

Aug 14, 2024

BUY
$22.73 - $40.85 $237,369 - $426,596
10,443 Added 32.51%
42,563 $1.74 Million
Q1 2024

May 14, 2024

BUY
$9.16 - $25.52 $294,219 - $819,702
32,120 New
32,120 $820,000
Q1 2023

May 12, 2023

BUY
$15.35 - $25.65 $970,580 - $1.62 Million
63,230 New
63,230 $971,000

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $1.6B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.